Literature DB >> 6600484

Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions.

P G Natali, R Cavaliere, A Bigotti, M R Nicotra, C Russo, A K Ng, P Giacomini, S Ferrone.   

Abstract

The antigenic heterogeneity of primary and metastatic lesions surgically removed from nine patients with nodular melanoma was investigated by using monoclonal antibodies to HLA-A, B antigens, to beta 2-microglobulin, to Ia antigens, and to melanoma-associated antigens (MAA). The latter include three types of membrane-bound MAA and a cytoplasmic MAA. In spite of an homogeneous morphologic appearance, multiple lesions removed from the same patient differed significantly in their reactivity with the panel of monoclonal antibodies in indirect immunofluorescence test. The extent of antigenic heterogeneity did not correlate with melanin synthesis, site of origin of the primary tumor, site of metastatic foci, or treatment, but was less marked in patients carrying the primary tumor. The antigenic heterogeneity of multiple lesions removed from one patient and the independent expression of the various types of MAA investigated suggest that combinations of monoclonal antibodies to MAA may be more effective than single antibodies for radioimaging and immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600484

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems.

Authors:  P Garin-Chesa; H R Beresford; A Carrato-Mena; H F Oettgen; L J Old; M R Melamed; W J Rettig
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 2.  Advances in the immunobiology of the skin. Implications for cutaneous malignancies.

Authors:  C A Romerdahl; M L Kripke
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

3.  Metastatic human melanoma. Phenotypic heterogeneity and antigen expression in relation to the clinical status.

Authors:  L Suter; E B Bröcker; H Ostmeier; J Schumann; C Sorg
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

4.  Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4.

Authors:  Xinhui Wang; Akihiro Katayama; Yangyang Wang; Ling Yu; Elvira Favoino; Koichi Sakakura; Alessandra Favole; Takahiro Tsuchikawa; Susan Silver; Simon C Watkins; Toshiro Kageshita; Soldano Ferrone
Journal:  Cancer Res       Date:  2011-10-21       Impact factor: 12.701

5.  Monoclonal antibodies against a human gastric cancer cell line with lung metastatic potential in nude mice define antigens with different expression between the primary and metastatic liver lesions.

Authors:  S Hokita; S Takao; T Muramatsu; H Shimazu
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10.

Authors:  M Maio; B Gulwani; S Tombesi; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma.

Authors:  P Nisticò; R Mortarini; L B De Monte; A Mazzocchi; M Mariani; F Malavasi; G Parmiani; P G Natali; A Anichini
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Selective in vitro toxicity of purothionin conjugated to the monoclonal antibody 225.28S to a human high-molecular-weight melanoma-associated antigen.

Authors:  K Imai; T Nakanishi; T Noguchi; A Yachi; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

9.  Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection.

Authors:  D W Bahler; J G Frelinger; L W Harwell; E M Lord
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

Review 10.  Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells.

Authors:  G Parmiani; G Fossati; D Taramelli; A Anichini; A Balsari; C Gambacorti-Passerini; G Sciorelli; N Cascinelli
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.